These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24475827)

  • 1. Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network.
    Hostage CA; Choudhury KR; Murali Doraiswamy P; Petrella JR;
    Radiology; 2014 Apr; 271(1):211-9. PubMed ID: 24475827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease.
    Hostage CA; Roy Choudhury K; Doraiswamy PM; Petrella JR;
    PLoS One; 2013; 8(2):e54483. PubMed ID: 23405083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease.
    Spampinato MV; Rumboldt Z; Hosker RJ; Mintzer JE;
    Radiology; 2011 Mar; 258(3):843-52. PubMed ID: 21163916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
    Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
    Wolk DA; Dickerson BC;
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain atrophy rates in first degree relatives at risk for Alzheimer's.
    Lampert EJ; Roy Choudhury K; Hostage CA; Rathakrishnan B; Weiner M; Petrella JR; Doraiswamy PM;
    Neuroimage Clin; 2014; 6():340-6. PubMed ID: 25379448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: A Longitudinal Study.
    Camarda C; Torelli P; Pipia C; Sottile G; Cilluffo G; Camarda R
    Curr Alzheimer Res; 2020; 17(8):766-780. PubMed ID: 33167837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.
    Chen K; Reiman EM; Alexander GE; Caselli RJ; Gerkin R; Bandy D; Domb A; Osborne D; Fox N; Crum WR; Saunders AM; Hardy J
    Am J Psychiatry; 2007 Jun; 164(6):916-21. PubMed ID: 17541051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
    Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
    Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Ngwa JS; Fungwe TV; Ntekim O; Allard JS; Johnson SM; Castor C; Graham L; Nadarajah S; Gillum RF; Obisesan TO;
    Dement Geriatr Cogn Disord; 2018; 45(1-2):66-78. PubMed ID: 29694964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
    Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
    Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping cerebral atrophic trajectory from amnestic mild cognitive impairment to Alzheimer's disease.
    Wei X; Du X; Xie Y; Suo X; He X; Ding H; Zhang Y; Ji Y; Chai C; Liang M; Yu C; Liu Y; Qin W;
    Cereb Cortex; 2023 Feb; 33(4):1310-1327. PubMed ID: 35368064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
    Fujishima M; Kawaguchi A; Maikusa N; Kuwano R; Iwatsubo T; Matsuda H; ;
    J Alzheimers Dis; 2017; 56(1):75-88. PubMed ID: 27911297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.